"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P46
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Champion, Brian R
Kodialbail, Prithvi
Illingworth, Sam
Rasiah, Nalini
Cochrane, Dan
Beadle, John
Fisher, Kerry
Brown, Alice CN
Article History
First Online: 6 November 2014